Posted on

cbd in retail

Cbd in retail

Traditional health product retailers such as CVS have announced the debut of CBD wellness products at more than 1,500 of their stores. The more interesting news is that non-health retailers are getting into the space as well – brands such as DSW and Nieman Marcus have announced that they will be including CBD in retail products this year. Most recently, Dollar General has announced it will include CBD products in more than 1,100 stores, crediting customer demand for adding it to their product mix. With Brightfield Group predicting that CBD will become a $22 billion industry, more retailers are sure to be joining the party.

What level of oversight currently exists for CBD products?

CBD products are already being sold to treat chronic pain, anxiety, depression, and joint health with a host of other potential treatments touted by brands, consumers, and advocacy groups every day. With the increase of these products in the marketplace, retailers are faced with the decision of joining the bandwagon or staying on the sidelines.

What is the FDA currently doing in relation to CBD in retail?

One of the biggest trends in self-care, health, and beauty today is the rise of cannabidiol products, popularly known as CBD. Found in the cannabis or marijuana plant, CBD is a naturally-occurring compound that’s gained momentum for the host of alternative-care therapeutic properties it offers. CBD does not produce any psychotropic or intoxicating effects – that is, CBD users do not experience the high that is associated with marijuana. CBD in retail is becoming more prevalent and many companies are struggling with the regulatory implications.

Cbd in retail

In the United States, cannabidiol products generated sales of roughly five billion U.S. dollars in 2020. By 2025, CBD product sales are predicted to reach nearly 17 billion U.S. dollars in the United States. With estimated sales of 730 million U.S. dollars, the state of California was the country’s leading market for CBD products. By 2025, nutraceuticals are forecast to become the largest CBD category in terms of U.S. sales.

This text provides general information. Statista assumes no liability for the information given being complete or correct. Due to varying update cycles, statistics can display more up-to-date data than referenced in the text.

While still a relatively small factor in consumer markets, CBD penetration is growing. In 2019, CBD accounted for four percent of the global vitamin and dietary supplements market. By 2027, this number is expected to grow to over 20 percent.

In the United States, cannabidiol products generated sales of roughly five billion U.S. dollars in 2020. By 2025, CBD product sales are predicted to reach nearly 17 billion U.S. dollars in the United States. With estimated sales of 730 million U.S. dollars, the state of California was the country’s leading market for CBD products. By 2025, nutraceuticals are forecast to become the largest CBD category in terms of U.S. sales.

State of the market

In the following 4 chapters, you will quickly find the 23 most important statistics relating to "CBD retail in the United States".

The most important key figures provide you with a compact summary of the topic of "CBD retail in the United States" and take you straight to the corresponding statistics.

This text provides general information. Statista assumes no liability for the information given being complete or correct. Due to varying update cycles, statistics can display more up-to-date data than referenced in the text.

Market penetration

CBD products come in many different shapes and sizes, including tea, vape products, and soaps. Within the food segment, oils and spreads were the most common types of cannabidiol products in 2019. In American convenience stores, vitamins were the leading CBD segment in terms of sales, generating over 20 million U.S. dollars in 2020. Overall, lotions and balms were the segment of CBD products that sparked the most interest among consumer in the U.S. followed by gummies, tinctures, and supplements.

Distribution of reasons why U.S. adults do not want to try CBD 2020